ClinicalTrials.Veeva

Menu

Analysis of Clinical Characteristics of Hemodialysis Patients With Omicron Infection

Shanghai Jiao Tong University logo

Shanghai Jiao Tong University

Status

Completed

Conditions

COVID-19

Treatments

Other: no intervention

Study type

Observational

Funder types

Other

Identifiers

NCT05559138
IIT-2022-0120

Details and patient eligibility

About

By collecting the clinical data of hemodialysis patients with Omicron infection in RenJi Hospital from April 7, 2022 to June 10, 2022, the clinical characteristics of this population were analyzed. And to analyze the risk factors of different clinical outcomes according to the clinical outcome of this population.

Full description

This study was a single-center, retrospective, observational study. The research subjects were hemodialysis patients admitted to the Hemodialysis Center of Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine because of omicron infection during the Omicron epidemic period from April 7, 2022 to June 10, 2022. 65 cases were included in the study after excluding those patients who underwent hemodialysis due to acute kidney injury. And they were compared with 195 non-dialysis patients admitted to the hospital in the same period,who were randomly selected, according to the ratio of 1:3.

Enrollment

260 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hemodialysis patients due to chronic kidney disease stage 5 with omicron infection

Exclusion criteria

  • Patients on hemodialysis due to acute kidney injury

Trial design

260 participants in 2 patient groups

hemodialysis patients with omicron infection
Description:
hemodialysis patients with omicron infection
Treatment:
Other: no intervention
non-hemodialysis patients with omicron infection
Description:
non-hemodialysis patients with omicron infection
Treatment:
Other: no intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems